Hipraviar-S
Hipraviar-S
Authorised
- Newcastle disease virus, strain La Sota, Live
Product identification
Medicine name:
Hipraviar-S
Active substance:
- Newcastle disease virus, strain La Sota, Live
Target species:
-
Chicken
Route of administration:
-
Ocular use
-
Nebulisation use
-
Oculonasal use
Product details
Active substance and strength:
-
Newcastle disease virus, strain La Sota, Live6.50/50% Embryo Infective Dose0.03millilitre(s)
Pharmaceutical form:
-
Suspension for oral suspension
Withdrawal period by route of administration:
-
Ocular use
-
Chicken
-
Meat and offal0day
-
-
-
Nebulisation use
-
Chicken
-
Meat and offal0day
-
-
-
Oculonasal use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 160/87 DGV
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Portuguese (PDF)
Published on: 20/06/2023
Updated on: 26/06/2023
How useful was this page?:
